194 results
Page 6 of 10
424B5
ghbirm3
16 Oct 15
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
lqtouoeh ki3
4 Dec 14
Departure of Directors or Certain Officers
12:00am
424B5
mc272nzyur13c
18 Jul 14
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
7tt21tr0t4m2cvh8nj8n
18 Jul 14
Entry into a Material Definitive Agreement
12:00am
424B5
be6ks38ka9ta1kr7pc0
14 Apr 14
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
lbnetys5x49
20 Mar 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
5px891fy
30 Oct 13
Other Events
12:00am
8-K
EX-99.1
99tf q2qg1xf
11 Sep 13
Other Events
12:00am
8-K
EX-99.1
g3bp323lq ys0l
29 Jul 13
Synta Announces ENCHANT-1 Breast Cancer Results Support Transition to Second Stage of Trial
12:00am
8-K
EX-99.1
va5o38
3 Jun 13
Synta Announces Positive Overall Survival Results From GALAXY-1 Phase 2b/3 Trial of Ganetespib in Second-Line Non-Small Cell Lung Cancer
12:00am